Calculate Your Salary Ranking
Home > Panacos Pharmaceuticals Salary

Panacos Pharmaceuticals Salary
  • 84
  • 16
  • 85

Panacos Pharmaceuticals average salary is $62,250, median salary is $62,250 with a salary range from $62,250 to $62,250.
Panacos Pharmaceuticals salaries are collected from government agencies and companies. Each salary is associated with a real job position. Panacos Pharmaceuticals salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
62,250
Average
62,250
Median
62,250
High
62,250
Total 1 Panacos Pharmaceuticals Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Microbiologist 62,250-62,250 Gaithersburg, MD, 20877 2010 Panacos Pharmaceuticals Microbiologist Salaries (1)
Panacos Pharmaceuticals Gaithersburg, MD Salaries
1
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Panacos Pharmaceuticals Salaries (July 27, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Panacos Pharmaceuticals salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Panacos Pharmaceuticals Information
  • Panacos Pharmaceuticals, Inc.
  • Industry: BioTech/Drugs
  • City: Watertown, MA
  • Panacos Pharmaceuticals is a biopharmaceutical company with a strategic focus on the discovery and development of novel antiviral drugs and vaccines.The Company's lead compounds are PA-344B and PA-457, potent HIV inhibitors with novel mechanisms of action compared with approved drugs. These compounds are currently in pre-clinical development and Panacos plans to file an IND to initiate human clinical testing in 2002.